Q1 RESULTS FOR DR LAL PATHLABS : EXPLAINED IN DETAIL ?

Dr Lal PathLabs announced a 51.94 percent decrease in its net Profit at Rs 28.4 crore for the quarter finished June 30, 2020.

The organization had posted a net benefit of Rs 59.1 crore for the relating time of the past monetary

Consolidated revenue from tasks of the organization remained at Rs 266 crore, as against Rs 335.2 crore in the year-prior period including patient volume down was 28.4 percent during the quarter.

This was a troublesome quarter, for Dr Lal Pathlabs, however for the whole country and the economy. Business was affected antagonistically, with volumes getting hit.

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk. He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk.

Leave a Reply